PATENT CLAIM ANALYSIS

Application Number: 16104045
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-02
Patent Classification: ["514", "020900"]

Abstract:
The invention features compounds of formula I or II: In one embodiment, the invention relates compounds and processes for conjugating ligand to oligonucleotide. The invention further relates to methods for treating various disorders and diseases such as viral infections, bacterial infections, parasitic infections, cancers, allergies, autoimmune diseases, immunodeficiencies and immunosuppression.

Claim (Index 16):
The oligonucleotide of  claim 3 , wherein the ligand is mannose, lactose, galactose, N-acetyl-galactosamine, N-acetyl glucosamine, multivalent lactose, multivalent galactose, multivalent mannose, multivalent fucose, multivalent N-acetyl-galactosamine, or multivalent N-acetyl glucosamine.

Metadata:
- Claim Count in Document: 23.0
- Percentile: 96.0
- Lexical Diversity: 1.46341
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13120389', '14918022', '13575461', '15395221', '12328537']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8416844782226078
- 35 USC 102 Novelty (BERT): 0.6015802830742738
- Combined Prediction Score: 0.8176740587077744
- Mean Citation Score: 502.440568
- Max Citation Score: 653.3163
- Similarity Product: 434.8059754552781

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test